WO2006025029A3 - Composition de divalproex a liberation prolongee - Google Patents
Composition de divalproex a liberation prolongee Download PDFInfo
- Publication number
- WO2006025029A3 WO2006025029A3 PCT/IB2005/052857 IB2005052857W WO2006025029A3 WO 2006025029 A3 WO2006025029 A3 WO 2006025029A3 IB 2005052857 W IB2005052857 W IB 2005052857W WO 2006025029 A3 WO2006025029 A3 WO 2006025029A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extended release
- divalproex
- release composition
- lactose
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1649/DEL/2004 | 2004-08-31 | ||
IN1649DE2004 | 2004-08-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006025029A2 WO2006025029A2 (fr) | 2006-03-09 |
WO2006025029A3 true WO2006025029A3 (fr) | 2006-05-18 |
Family
ID=35636703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/052857 WO2006025029A2 (fr) | 2004-08-31 | 2005-08-31 | Composition de divalproex a liberation prolongee |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006025029A2 (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000037055A1 (fr) * | 1998-12-18 | 2000-06-29 | Abbott Laboratories | Preparation a liberation controlee de divalproex sodium |
WO2002051402A1 (fr) * | 2000-12-22 | 2002-07-04 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
WO2002051401A2 (fr) * | 2000-12-22 | 2002-07-04 | Abbott Laboratories | Formulation a liberation controlee de sodium de divalproex |
WO2003103635A1 (fr) * | 2002-06-07 | 2003-12-18 | Ranbaxy Laboratories Limited | Formulation de divalproex de sodium a liberation prolongee |
WO2004071424A2 (fr) * | 2003-02-05 | 2004-08-26 | Teva Pharmaceutical Industries, Ltd. | Preparation de n-(2-propylpentanoyl)glycinamide a liberation immediate |
-
2005
- 2005-08-31 WO PCT/IB2005/052857 patent/WO2006025029A2/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000037055A1 (fr) * | 1998-12-18 | 2000-06-29 | Abbott Laboratories | Preparation a liberation controlee de divalproex sodium |
WO2002051402A1 (fr) * | 2000-12-22 | 2002-07-04 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
WO2002051401A2 (fr) * | 2000-12-22 | 2002-07-04 | Abbott Laboratories | Formulation a liberation controlee de sodium de divalproex |
WO2003103635A1 (fr) * | 2002-06-07 | 2003-12-18 | Ranbaxy Laboratories Limited | Formulation de divalproex de sodium a liberation prolongee |
WO2004071424A2 (fr) * | 2003-02-05 | 2004-08-26 | Teva Pharmaceutical Industries, Ltd. | Preparation de n-(2-propylpentanoyl)glycinamide a liberation immediate |
Also Published As
Publication number | Publication date |
---|---|
WO2006025029A2 (fr) | 2006-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007004294A (es) | Composiciones farmaceuticas que comprenden levetiracetam y proceso para su preparacion. | |
WO2006024479A3 (fr) | Compositions pharmaceutiques | |
WO2005089729A3 (fr) | Formulations galeniques de composes organiques | |
EP1834637A4 (fr) | Preparation prophylactique/therapeutique contre une maladie due aux radicaux libres | |
WO2004093884A3 (fr) | Sachet de mesalazine a forte charge en substance medicamenteuse | |
WO2007146248A3 (fr) | Préparations de laquinimod stables | |
EP1736160A4 (fr) | Oligosaccharides d'algine et derives de ceux-ci ainsi que leur fabrication et leur utilisation | |
WO2001090091A8 (fr) | Inhibiteurs de 11-beta-hydroxy-steroide-deshydrogenase de type 1 | |
EP1578403A4 (fr) | Compositions de milnaciprane a liberation modifiee | |
IL188758A (en) | Tetrahydrobenzazepines are stored in aryl and heteroaryl, containing pharmaceutical preparations and methods for preparing them | |
WO2006119283A3 (fr) | Compositions anti-odeurs et utilisation therapeutique associee | |
IL183360A (en) | 12-aryl prostaglandin analogs, compositions comprising them and their use in the preparation of medicaments | |
WO2003049680A3 (fr) | Compositions contenant des antihistaminiques sedatifs et des antihistaminiques non sedatifs | |
WO2003053359A3 (fr) | 1,3-bis-(phenyl-substitue)-2-propyne-1-ones et leur utilisation pour le traitement d'affections | |
SE0501556L (sv) | Förstärkt absorption | |
WO2008006514A8 (fr) | Combinaisons de principes actifs ayant des propriétés insecticides et acaricides | |
WO2007132134A3 (fr) | Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations | |
EP1874298A4 (fr) | Procedes et compositions de production, formulation et utilisation de 1-aryl-3-azabicyclo[3,1,0]hexanes | |
WO2006056696A3 (fr) | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation | |
WO2004047792A3 (fr) | Glucocorticoides liposomaux | |
UA94025C2 (ru) | Применение антагонистов рецептора св1 для производства композиции для лечения фиброза печени | |
WO2005110413A3 (fr) | Medicaments contenant des n-sulfamoyl-n'-arylpiperazines utilises pour la prophylaxie ou le traitement de l'obesite et des pathologies apparentees | |
BR0311327A (pt) | Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo | |
WO2006046871A3 (fr) | Composition peri-operatoires contenant lactobacillus rhamnosus | |
AU2003297840A1 (en) | Chemopreventive and therapeutic aspects of polyphenolic compositions and assays |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1637/DELNP/2007 Country of ref document: IN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |